CIRAFICI, ANNA MARIA
CIRAFICI, ANNA MARIA
Istituto di Endocrinologia e Oncologia Sperimentale ''G. Salvatore'' - IEOS
A failure mode and effect analysis (FMEA)-based approach for risk assessment of scientific processes in non-regulated research laboratories
2020 Mascia, A; Cirafici, Am; Bongiovanni, A; Colotti, G; Lacerra, G; Di Carlo, M; Digilio, Fa; Liguori, Gl; Lanati, A; Kisslinger, A
Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells
2020 Allocca, Chiara; Cirafici, ANNA MARIA; Laukkanen Mikko, O; Castellone, MARIA DOMENICA
Quality-based model for Life Sciences research guidelines
2016 Digilio, F Anna; Lanati, Antonella; Bongiovanni, Antonella; Mascia, Anna; DI CARLO, Marta; Barra, Adriano; Cirafici, ANNA MARIA; Colotti, Gianni; Kisslinger, Annamaria; Lacerra, Giuseppina; Liguori Giovanna, L
The qPMO network: quality management tools to improve research efficiency, reproducibility, data management and dissemination
2016 Bongiovanni, A; Liguori, Gl; Colotti, G; Cirafici, Am; Di Carlo, M; Digilio, Fa; Lacerra, G; Lanati, A; Mascia, A; Kisslinger, A
Applying Quality principles and Project Management methodologies in biomedical research: a public research network's case study.
2015 Bongiovanni A.; Colotti G.; Liguori G.L.; Di Carlo M.; Digilio F.A.; Lacerra G.; Mascia A.; Cirafici A.M.; Barra A.; Lanati A.;Kisslinger A.
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma.
2007 Salvatore G; Nappi TC; Salerno P; Jiang Y; Garbi C; Ugolini C; Miccoli P; Basolo F; Castellone MD; Cirafici AM; Melillo RM; Fusco A; Bittner ML; Santoro M.
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase.
2007 De Falco, V; Castellone, Md; De Vita, G; Cirafici, Am; Hershman, Jm; Guerrero, C; Fusco, A; Melillo, Rm; Santoro, M
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness.
2005 Guarino, V; Faviana, P; Salvatore, G; Castellone, Md; Cirafici, Am; De Falco, V; Celetti, A; Giannini, R; Basolo, F; Melillo, Rm; Santoro, M
RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors.
2005 De Falco, V; Guarino, V; Malorni, L; Cirafici, Am; Troglio, F; Erreni, M; Pelicci, G; Santoro, M; Melillo, Rm
The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
2004 Melillo, Rm; Cirafici, Am; De Falco, V; Bellantoni, M; Chiappetta, G; Fusco, A; Carlomagno, F; Picascia, A; Tramontano, D; Tallini, G; Santoro, M
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes
2003 Castellone M.D. ; Cirafici A.M. ; De Vita G. ; De Falco V. ; Malorni L. ; Tallini G. ; Fagin J.A.; Fusco A. ; Melillo R.M. ; Santoro M.
Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
2002 Fusco A; Chiappetta G; Hui P; GarciaRostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G.
Ret-mediated mitogenesis requires Src kinase activity
1999 Melillo RM; Barone MV; Lupoli G; Cirafici AM; Carlomagno F; Visconti R; Matoskova B; Di Fiore PP; Vecchio G; Fusco A; Santoro M
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential
1997 Cirafici AM; Salvatore G; De Vita G; Carlomagno F; Dathan NA; Visconti R; Melillo RM; Fusco A; Santoro M
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype.
1997 Carlomagno F; Salvatore G; Cirafici AM; De Vita G; Melillo RM; de Franciscis V; Billaud M; Fusco A; Santoro M.
Loss of thyrotropin regulation and transforming growth factor beta-induced growth arrest in erbB-2 overexpressing rat thyroid cells.
1993 Mincione, G; Cirafici, Am; Lazzareschi, D; Pepe, S; Ciardiello, F; Colletta, G
Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase.
1993 Tortora, G; Pepe, S; Cirafici, Am; Ciardiello, F; Porcellini, A; Clair, T; Colletta, G; Chochung, Ys; Bianco, Ar
TGF Beta inhibits rat thyroid cell proliferation without alterations in the expression of TSH-induced cell cycle-related genes
1992 Cirafici, ANNA MARIA; Pepe, Stefano; Mincione, Gabriella; Esposito, Diana; Colletta, Giulia
TSH is able to induce cell cycle-related gene expression in rat thyroid cell.
1992 Colletta G; Cirafici AM.
Constitutive expression of transforming growth factor alpha does not transform rat thyroid epithelial cells.
1991 Colletta G; Cirafici AM; Di Carlo A; Ciardiello F; Salomon DS; Vecchio G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A failure mode and effect analysis (FMEA)-based approach for risk assessment of scientific processes in non-regulated research laboratories | 1-gen-2020 | Mascia, A; Cirafici, Am; Bongiovanni, A; Colotti, G; Lacerra, G; Di Carlo, M; Digilio, Fa; Liguori, Gl; Lanati, A; Kisslinger, A | |
| Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells | 1-gen-2020 | Allocca, Chiara; Cirafici, ANNA MARIA; Laukkanen Mikko, O; Castellone, MARIA DOMENICA | |
| Quality-based model for Life Sciences research guidelines | 1-gen-2016 | Digilio, F Anna; Lanati, Antonella; Bongiovanni, Antonella; Mascia, Anna; DI CARLO, Marta; Barra, Adriano; Cirafici, ANNA MARIA; Colotti, Gianni; Kisslinger, Annamaria; Lacerra, Giuseppina; Liguori Giovanna, L | |
| The qPMO network: quality management tools to improve research efficiency, reproducibility, data management and dissemination | 1-gen-2016 | Bongiovanni, A; Liguori, Gl; Colotti, G; Cirafici, Am; Di Carlo, M; Digilio, Fa; Lacerra, G; Lanati, A; Mascia, A; Kisslinger, A | |
| Applying Quality principles and Project Management methodologies in biomedical research: a public research network's case study. | 1-gen-2015 | Bongiovanni A.; Colotti G.; Liguori G.L.; Di Carlo M.; Digilio F.A.; Lacerra G.; Mascia A.; Cirafici A.M.; Barra A.; Lanati A.;Kisslinger A. | |
| A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. | 1-gen-2007 | Salvatore G; Nappi TC; Salerno P; Jiang Y; Garbi C; Ugolini C; Miccoli P; Basolo F; Castellone MD; Cirafici AM; Melillo RM; Fusco A; Bittner ML; Santoro M. | |
| RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. | 1-gen-2007 | De Falco, V; Castellone, Md; De Vita, G; Cirafici, Am; Hershman, Jm; Guerrero, C; Fusco, A; Melillo, Rm; Santoro, M | |
| Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. | 1-gen-2005 | Guarino, V; Faviana, P; Salvatore, G; Castellone, Md; Cirafici, Am; De Falco, V; Celetti, A; Giannini, R; Basolo, F; Melillo, Rm; Santoro, M | |
| RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors. | 1-gen-2005 | De Falco, V; Guarino, V; Malorni, L; Cirafici, Am; Troglio, F; Erreni, M; Pelicci, G; Santoro, M; Melillo, Rm | |
| The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. | 1-gen-2004 | Melillo, Rm; Cirafici, Am; De Falco, V; Bellantoni, M; Chiappetta, G; Fusco, A; Carlomagno, F; Picascia, A; Tramontano, D; Tallini, G; Santoro, M | |
| Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes | 1-gen-2003 | Castellone M.D. ; Cirafici A.M. ; De Vita G. ; De Falco V. ; Malorni L. ; Tallini G. ; Fagin J.A.; Fusco A. ; Melillo R.M. ; Santoro M. | |
| Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. | 1-gen-2002 | Fusco A; Chiappetta G; Hui P; GarciaRostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G. | |
| Ret-mediated mitogenesis requires Src kinase activity | 1-gen-1999 | Melillo RM; Barone MV; Lupoli G; Cirafici AM; Carlomagno F; Visconti R; Matoskova B; Di Fiore PP; Vecchio G; Fusco A; Santoro M | |
| Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential | 1-gen-1997 | Cirafici AM; Salvatore G; De Vita G; Carlomagno F; Dathan NA; Visconti R; Melillo RM; Fusco A; Santoro M | |
| The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. | 1-gen-1997 | Carlomagno F; Salvatore G; Cirafici AM; De Vita G; Melillo RM; de Franciscis V; Billaud M; Fusco A; Santoro M. | |
| Loss of thyrotropin regulation and transforming growth factor beta-induced growth arrest in erbB-2 overexpressing rat thyroid cells. | 1-gen-1993 | Mincione, G; Cirafici, Am; Lazzareschi, D; Pepe, S; Ciardiello, F; Colletta, G | |
| Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase. | 1-gen-1993 | Tortora, G; Pepe, S; Cirafici, Am; Ciardiello, F; Porcellini, A; Clair, T; Colletta, G; Chochung, Ys; Bianco, Ar | |
| TGF Beta inhibits rat thyroid cell proliferation without alterations in the expression of TSH-induced cell cycle-related genes | 1-gen-1992 | Cirafici, ANNA MARIA; Pepe, Stefano; Mincione, Gabriella; Esposito, Diana; Colletta, Giulia | |
| TSH is able to induce cell cycle-related gene expression in rat thyroid cell. | 1-gen-1992 | Colletta G; Cirafici AM. | |
| Constitutive expression of transforming growth factor alpha does not transform rat thyroid epithelial cells. | 1-gen-1991 | Colletta G; Cirafici AM; Di Carlo A; Ciardiello F; Salomon DS; Vecchio G. |